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Introduction
Antimicrobial prescriptions are a new data source available to the
Veterans Health Administration (VHA) biosurveillance program. Lit-
tle is known about whether antiviral or antibacterial prescription data
correlates with influenza ICD-9-CM coded encounters. We therefore
evaluated the utility and timeliness of antiviral and antibacterial uti-
lization for influenza surveillance.
Methods
Antiviral (oseltamivir, zanamivir) and antibacterial (azithromycin)
outpatient (OP) prescriptions and OP ESSENCE coded respiratory
syndrome, influenza-like-illness (ILI) or influenza-specific ICD-9-
CM coded visits were analyzed covering the 2010-2011 and 2011-
2012 influenza seasons (July 1, 2010-July 31, 2012) for 152 VA
medical centers and 971 outpatient clinics using VA Corporate Data
Warehouse and ESSENCE biosurveillance tool. Correlation analysis
and peak comparisons were performed.
Results
For this time period, there were 2,880,415 respiratory, 1,578,421
ILI, and 5,158 influenza-specific coded visits. For both influenza sea-
sons, respiratory and ILI visits peaked at weeks 1-2 whereas in-
fluenza-specific visits had two peaks between weeks 37-40 and weeks
6-11 (See Figure 1 and 2). The total number of prescriptions was
631,272 azithromycin; 8,362 oseltamivir; and 88 zanamivir (See Fig-
ure 2). Spearman rank correlation coefficients for daily antiviral pre-
scriptions and influenza-coded visits were (0.70); ILI visits (0.64),
and respiratory illness visits (0.62), respectively; and for azithromycin
prescriptions 0.77, 0.98, and 0.97 respectively. Oseltamivir and
zanamivir prescriptions only increased in 2010-2011 starting with
week 51 and peaking week 6 and in 2011-2012 starting with week 8
and peaking week 14. However, azithromycin prescriptions tracked
better across the entire influenza season (peaking at weeks 1-2 for
both influenza seasons).
Conclusions
VA outpatient prescription data indicated that significantly more
ILI and respiratory syndrome visits occurred compared to antiviral
prescriptions dispensed with marginal temporal correlation between
visits and antiviral prescriptions. Reasons for this finding require fur-
ther investigation. Although we did not chart review the visit code
and antimicrobial prescription in individual records, possible factors
may be related to later presentation of cases, perceived lack of effi-
cacy of antivirals, or insufficient coding of influenza. Thus, antiviral
prescription data provided minimal additional information for in-
fluenza trend monitoring in VA although may still be useful a marker
of more severe illness. Interestingly, azithromycin use tracked better
with the onset and peaks of the influenza season. Further investiga-
tion is also needed to determine whether patients with influenza-spe-
cific coded encounters were also prescribed azithromycin and why
relatively few encounters were coded with an influenza-specific code.
Figure 1: Daily respiratory (Resp) [green], Influenza-like Illness (ILI) [pur-
ple], and Influenza-specific [yellow] encounters compared to azithromycin
(Azithro) [blue] and oseltamivir and zanamivir [red] orders in VA facilities
nationally from July 1, 2010-July 31, 2012.
Figure 2: Detailed view of daily influenza-specific coded encounters [yel-
low] and azithromycin (azithro) [blue], oseltamivir and zanamivir [red] or-
ders in VA facilities nationally from July 1, 2010-July 31, 2012.
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